The Role of Teicoplanin in the Treatment of Febrile Neutropenia

References

• Menichetti F, Martino P, Bucaneve G, and the GIMEMA Infection Program. Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile neutropenic patients with haematological malignancies. Antimicrob Agents Chemother 1994; 38: 2041-6.
   Google Scholar
• Rubio M, Palau L, Vivas J, et al. Predominance of Gram-positve microorganisms as a cause of septiceamia in patients with haematological malignancies. Infect Control Hosp Epidemiol 1994; 15: 101-4.
   Google Scholar
• Beam TR Jr, Kunin CM. Guidelines for the evaluation of anti-infective drug products. Clin Infect Dis 1992; 15 (Suppl 1): S5-32.
   Google Scholar
• Kureishi A, Jewesson P, Rubinger, M, et al. Doubleblind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacilln: effect on cyclosporin A–associated nephrotoxicity. Antimicrob Agents Chemother 1991; 35: 2246-52.
   Google Scholar
• Wilson APR, Grüneberg RN, Neu H. A critical review of the dosage of teicoplanin in Europe and the USA. J Antimicrob Chemother 1996; 38: 507-21.
   Google Scholar
• Felmingham D. Towards the ideal glycopeptide. J Antimicrob Chemother 1993; 32: 663-6.
   Google Scholar
• Davies JM. A survey of the use of teicoplanin in patients with haematological malignancies and solid tumours. Infection 1998; 26: 389-95.
   Google Scholar
• Wilson APR, Grüneberg RN. Infections in patients with haematological malignancies and solid tumours. In: Teicoplanin – the first decade. Chapter 5. Abingdon, UK: The Medicine Group (Education) Ltd., 1997: 57-64.
   Google Scholar
• Smith S, Cheesbrough J, Spearing R, Davies J. Randomised prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters. Antimicrob Agents Chemother 1989; 33: 1193-7.
   Google Scholar
• Rolston K, Nguyen, H, Amos G, Elting L, Fainstein V, Bodey G. A randomised clinical trial of vancomycin versus teicoplanin for the treatment of Gram-positive bacterial infections in immuno-compromised hosts. Antimicrob Agents Chemother 1994; 35: 451-7.
   Google Scholar
• Van der Auwera P, Aoun M, Meunier F. Randomised study of vancomycin versus teicoplanin for the treatment of Gram-positive bacterial infections in immunocompromised hosts. Antimicrob Agents Chemother 1991; 35: 451-7.
   Google Scholar
• Schaison GS. Cost effectiveness of teicoplanin plus ceftriaxone: a once daily antibiotic regimen. Paed Infect Dis J 1993; 12: S14-S16.
   Google Scholar
• Cony-Makhoul P, Brossard G, Marit G, Pellegrin J, Texier-Maugein J, Reiffers J. A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients. Br J Haematol 1990; 76 Suppl. 2: 35-40.
   Google Scholar
• Choi J, Kim Y, Shin W, et al. A randomized study comparing clinical efficacy of ceftazidime plus aztreonam plus teicoplanin or vancomycin containing regimen in febrile granulocytopenic patients. J Kor Soc Chemother 1992; 10: 165-71.
   Google Scholar
• Hernandez L, Figuera A, Jiminez ML, et al. Empiric antibiotic regimen for febrile neutropenia. Imipenem plus vancomycin vs imipenem plus teicoplanin as initial therapy. Bone Marrow Transplant 1994; Suppl. 162.
   Google Scholar
• Contra T, Martin N, Scaglione C, Madero L, Diaz MA. A study of teicoplanin (T) and vancomycin (V) in combination therapy for febrile episodes in neutropenic paediatric patients. Can J Infect Dis. 1995; 6 Suppl. C: 309C.
   Google Scholar
• Micozzi A, Nucci M, Venditti M, et al. Piperacillin/tazobactam/amikacin versus piperacillin / amikacin / teicoplanin in the empirical treatment of neutropenic patients. Eur J Clin Microbiol Infect Dis 1993; 12: 1-8.
   Google Scholar
• Spencer R, Winfield D, Harding I. A comparative study of teicoplanin and aztreonam versus piperacillin and gentamicin in haematology patients with clinically diagnosed septicaemia. Int J Antimicrob. Agents 1992; 1, Suppl. 1: 15-20.
   Google Scholar
• Martino P, Micozzi A, Gentile G, Raccah R, Girmenia C, Mandelli F. Piperacillin plus amikacin vs piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis. Clin Infect Dis 1992; 15: 290-4.
   Google Scholar
• Gerard M, Van der Auwera P, Meunier F, Ninove D, Daneau D, Klastersky J. A controlled clinical trial on efficacy and safety of teicoplanin versus vancomycin in the treatment of staphylococcal infections. In Program and Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy, New York, 1987. Washington D.C.: American Society for Chemotherapy, 1987: 278, Abstract No. 1039.
   Google Scholar
• Van Laetham Y, Hermans P, De Wit S, Goosens H, Clumeck N. Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results. J Antimicrob Chemother 1988; 21 Suppl. A: 81-7.
   Google Scholar
• Kulmala, Data on file, HMR, 1990.
   Google Scholar
• Gilbert DN, Wood CA, Kimbrough RC, and the Infectious disease Consortium of Oregon. Failure of treatment with teicoplanin at 6 milligrams / kilogram / day in patients with Staphylococcus aureus intravascular infection. Antimicrob Agents Chemother 1991; 35: 79-87.
   Google Scholar
• Charbonneau P, Harding I, Garaud JJ, Aubertin J, Brunet F, Domart Y. Teicoplanin: a well-tolerated and easily administered alternative to vancomycin for gram positive infections in intensive care patients. Int Care Med 1994; 20: S35-42.
   Google Scholar
• Hedström SA. Teicoplanin vs vancomycin in severe Gram positive infection–a multicentre Scandinavian trial. Abstracts of the 7th European Congress of Clinical Microbiology and Infectious Diseases, 1995; Vienna: Excerpta Medica Medical Communications b.v. 1995: 147, Abstract 760.
   Google Scholar
• Neville L, Brumfitt W, Hamilton-Miller JMT, Harding I. Teicoplanin vs vancomycin for the treatment of serious infections: a randomised trial. Int J Antimicrob Agents 1995; 21 Suppl. A: 123-31.
   Google Scholar
• Studena M, Hlavacova E, Hel’Pianski L, et al. A comparison of teicoplanin/netilmycin and teicoplanin/perfloxacin in the management of febrile neutropenia. Chemotherapy 1994; 40: 431-4.
   Google Scholar
• Lui C-Y, Lee W-S, Fung C-P, et al. Comparative study of teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia. Clin Drug Invest 1996; 12: 80-7.
   Google Scholar
• Bucaneve G, Menichetti F, Del Favero A. Cost analysis of 2 empiric antibacterial regimens containing glycopeptides for the treatment of febrile neutropenia in patients with acute leukemia. Pharmacoeconomics 1999; 15: 85-95.
   Google Scholar